Basics Inhibrx, Inc. IPO Date: August 19, 2020 Sector: Healthcare Industry: Biotech Market Cap: $166.04M Activated in VL: True Average Daily Range Avg Daily Range: $0.79 | 3.45% Avg Daily Range (30 D): $0.30 | 2.36% Avg Daily Range (90 D): $0.34 | 2.57% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .1M Avg Daily Volume (90 D): .08M Trade Size Avg Trade Size (Sh.): 64 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 57 Institutional Trades Total Inst.Trades: 1,237 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $.59M Avg Inst. Trade (90 D): $.78M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.17M Avg Closing Trade (30 D): $.56M Avg Closing Trade (90 D): $1.23M Avg Closing Volume: 82.15K         News Jul 23, 2024 @ 9:01 AM Inhibrx stock rated 'Market Perform' by JMP after ... Source: Emilio Ghigini Feb 28, 2024 @ 3:25 PM Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue... Source: Zacks Equity Research Feb 22, 2024 @ 10:15 PM BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings a... Source: Zacks Equity Research Jan 25, 2024 @ 2:26 PM Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY... Source: Kinjel Shah Jan 24, 2024 @ 3:42 PM Biotech Stock Roundup: GILD Down on Study Results,... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $114.01 $-5.03 $114.01 Diluted EPS $112.62 $-4.47 $112.62 Revenue $ .2M $ .1M $ .2M Gross Profit $ $ $ Net Income / Loss $ 1.69B $ -47.87M $ 1.69B Operating Income / Loss $ -331.45M $ -49.93M $ -331.45M Cost of Revenue $ $ $ Net Cash Flow $ -125.33M $ -43.74M $ -125.33M PE Ratio 0.11